Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Net Income 2016–2025
Oramed Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2016 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Oramed Pharmaceuticals Inc. net income for the quarter ending March 31, 2025 was -7.6 M, a 125.10% increase year-over-year.
- Oramed Pharmaceuticals Inc. net income for the twelve months ending March 31, 2025 was -19.3 M, a 53.62% decrease year-over-year.
- Oramed Pharmaceuticals Inc. annual net income for 2025 was 64.0 M, a 1158.84% increase from 2023.
- Oramed Pharmaceuticals Inc. annual net income for 2023 was 5.1 M, a 113.92% decrease from 2022.
- Oramed Pharmaceuticals Inc. annual net income for 2022 was -36.6 M, a 59.04% increase from 2021.
- Oramed Pharmaceuticals Inc. annual net income for 2021 was -23.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Oramed Pharmaceuticals Inc. Net Income — FAQ
Oramed Pharmaceuticals Inc. (ORMP) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Oramed Pharmaceuticals Inc.'s net income?
Oramed Pharmaceuticals Inc. (ORMP) reported net income of $64M for fiscal 2025.
Where can I see ORMP's net income history?
The chart and table above show Oramed Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.